In addition, CBP treatment had no effect on apoptosis (%caspase-3+ cells; Supplementary Figure 1A) compared to Nf1OPG mice and minimal effects on tumor-associated monocytes (TAM; %Iba1+ cells; Supplementary Figure 1B), but reduced CD8+ T cell (Supplementary Figure 1C), Olig2+ cell (Supplementary Figure 1D), and BLBP+ cell (Supplementary Figure 1E) content to levels comparable to those seen in Nf1+/- mice. The gene discussed is CASP3; the disease is neoplasm.